Gecina Nom
Gecina Nom operates in various business sectors.
Gecina Nom (GI6A) - Net Assets
Latest net assets as of December 2023: €10.60 Billion EUR
Based on the latest financial reports, Gecina Nom (GI6A) has net assets worth €10.60 Billion EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€17.65 Billion) and total liabilities (€7.05 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.60 Billion |
| % of Total Assets | 60.06% |
| Annual Growth Rate | -2.04% |
| 5-Year Change | -16.71% |
| 10-Year Change | N/A |
| Growth Volatility | 8.57 |
Gecina Nom - Net Assets Trend (2018–2023)
This chart illustrates how Gecina Nom's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gecina Nom (2018–2023)
The table below shows the annual net assets of Gecina Nom from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €10.60 Billion | -17.07% |
| 2022-12-31 | €12.78 Billion | -1.56% |
| 2021-12-31 | €12.98 Billion | +3.84% |
| 2020-12-31 | €12.50 Billion | -1.75% |
| 2019-12-31 | €12.73 Billion | +8.30% |
| 2018-12-31 | €11.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gecina Nom's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 277.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €12.37 Billion | 116.89% |
| Total Equity | €10.58 Billion | 100.00% |
Gecina Nom Competitors by Market Cap
The table below lists competitors of Gecina Nom ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NEW YORK TIMES -A- (NYT.SG)
STU:NYT
|
$638.44K |
|
Ovoca Gold PLC
IR:OVXA
|
$638.59K |
|
ISIS PHARMACEUTICAL
BE:ISI
|
$638.61K |
|
Ribbon Acquisition Corp Rights
NASDAQ:RIBBR
|
$639.28K |
|
Turbo Mech Bhd
KLSE:5167
|
$636.52K |
|
Brewbilt Brewing Co
PINK:BRBL
|
$635.90K |
|
Retail Estates SA
STU:R6N
|
$634.91K |
|
VIENNA INSURANCE GR
BE:WSV2
|
$634.75K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gecina Nom's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 12,757,236,000 to 10,582,743,000, a change of -2,174,493,000 (-17.0%).
- Net loss of 1,787,184,000 reduced equity.
- Dividend payments of 391,317,000 reduced retained earnings.
- Share repurchases of 36,000 reduced equity.
- New share issuances of 4,100,000 increased equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.79 Billion | -16.89% |
| Dividends Paid | €391.32 Million | -3.7% |
| Share Repurchases | €36.00K | -0.0% |
| Share Issuances | €4.10 Million | +0.04% |
| Other Changes | €-56.00K | -0.0% |
| Total Change | €- | -17.05% |
Book Value vs Market Value Analysis
This analysis compares Gecina Nom's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.48x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €158.13 | €68.55 | x |
| 2019-12-31 | €166.20 | €68.55 | x |
| 2020-12-31 | €169.48 | €68.55 | x |
| 2021-12-31 | €175.76 | €68.55 | x |
| 2022-12-31 | €172.86 | €68.55 | x |
| 2023-12-31 | €143.24 | €68.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gecina Nom utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -16.89%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -213.86%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.67x
- Recent ROE (-16.89%) is below the historical average (2.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 8.57% | 110.28% | 0.05x | 1.68x | €-167.20 Million |
| 2019 | 11.93% | 184.49% | 0.04x | 1.61x | €245.37 Million |
| 2020 | 1.24% | 19.20% | 0.04x | 1.62x | €-1.09 Billion |
| 2021 | 6.56% | 112.44% | 0.04x | 1.58x | €-446.34 Million |
| 2022 | 1.33% | 22.16% | 0.04x | 1.62x | €-1.11 Billion |
| 2023 | -16.89% | -213.86% | 0.05x | 1.67x | €-2.85 Billion |
Industry Comparison
This section compares Gecina Nom's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.